Aligos Therapeutics Ratios (2021-2025) | ALGS

Ratios Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin -3,036.15%-1,928.16%-2,146.91%-10,292.10%-1,383.20%-538.23%-454.55%-617.39%-887.19%-419.98%-836.21%-1,389.85%-5,020.03%494.82%-1,533.44%-13,551.65%13,868.49%-1,624.66%-4,248.45%
EBIT Margin -3,048.35%-1,913.59%-2,151.46%-10,340.05%-1,383.00%-552.21%-461.47%-641.28%-925.98%-445.76%-885.38%-1,294.03%-3,176.66%-2,489.54%-1,610.48%-3,393.23%-6,187.46%-1,924.04%-3,827.40%
EBITDA Margin -3,045.38%-1,931.52%-2,155.04%-10,085.01%-1,394.90%-543.68%-450.85%-611.93%-884.90%-437.66%-837.56%-1,385.96%-5,033.43%478.70%-1,534.08%-13,576.90%13,853.38%-1,646.63%-4,251.28%
Operating Margin -3,048.35%-1,913.59%-2,151.46%-10,340.05%-1,383.00%-552.21%-461.47%-641.28%-925.98%-445.76%-885.38%-1,294.03%-3,176.66%-2,489.54%-1,610.48%-3,393.23%-6,187.46%-1,924.04%-3,827.40%
Net Margin -3,041.10%-1,929.97%-2,155.11%-10,276.29%-1,385.26%-539.51%-453.51%-618.77%-888.70%-437.61%-837.56%-1,388.35%-5,023.49%477.00%-1,540.72%-13,556.11%13,854.66%-1,643.83%-4,256.01%
FCF Margin -3,308.02%-1,499.68%-1,656.80%-10,304.09%-814.82%-686.95%-417.44%-477.07%-866.98%-317.09%-944.10%-1,127.82%-3,277.52%-1,837.23%-1,608.08%-3,036.80%-6,723.15%-1,606.63%-3,285.43%
Efficiency
Assets Average 223.21M237.47M249.22M222.92M196.50M173.30M155.38M134.22M113.93M95.99M118.69M139.71M118.36M98.62M79.26M110.40M142.70M122.23M
Equity Average 182.05M192.95M200.87M168.81M144.93M129.50M112.96M94.33M77.19M62.23M73.45M75.94M63.51M58.66M10.56M43.74M109.16M86.85M
Invested Capital 195.22M168.88M217.01M184.73M152.89M136.98M122.01M103.90M84.75M69.64M54.82M92.08M59.80M67.23M50.10M-28.97M116.44M101.87M71.83M
Asset Utilization Ratio 0.020.030.040.060.090.100.130.130.090.070.050.050.050.030.020.02
Leverage & Solvency
Equity Ratio 0.830.800.820.780.730.750.740.710.700.660.640.610.470.620.57-0.410.770.760.65
Valuation
Enterprise Value -213.41M-190.65M-242.19M-190.73M-183.22M-159.34M-142.30M-125.83M-103.52M-90.87M-70.50M-135.80M-201.29M-143.96M-114.49M-56.94M-202.00M-227.18M-156.25M
Return Ratios
Return on Sales -30.41%-19.30%-21.55%-102.76%-13.85%-5.40%-4.54%-6.19%-8.89%-4.38%-8.38%-13.88%-50.23%4.77%-15.41%-135.56%138.55%-16.44%-42.56%
Return on Capital Employed -0.61%-0.75%-0.77%-0.79%-0.80%-0.81%-0.98%-1.15%-0.93%-0.71%-0.99%-1.22%-1.55%-0.94%-0.64%-0.87%
Return on Invested Capital -0.64%-0.81%-0.88%-0.87%-0.86%-0.91%-1.11%-1.38%-1.21%-1.14%-1.48%-1.62%-8.46%-1.99%-0.72%-1.00%
Return on Assets -0.51%-0.61%-0.64%-0.65%-0.62%-0.62%-0.72%-0.85%-0.74%-0.71%-0.64%-0.78%-1.66%-0.48%-0.52%-0.71%
Return on Equity -0.64%-0.81%-0.87%-0.86%-0.85%-0.88%-1.07%-1.31%-1.19%-1.31%-1.19%-1.31%-12.42%-1.22%-0.68%-1.00%